Oncology
Through research programs, we aim to change the tomorrow of patients suffering from solid tumours, such as Prostate Cancer, and haematologic malignancies.
With approximately 20% of our sales earmarked for research, we aim to build a strong presence in therapeutic areas where a large number of unmet medical needs still exist.
Currently we have 12 different molecules in clinical development phase in Oncology. Through these research programs, we aspire to change the tomorrow of patients suffering from solid tumors such as Prostate Cancer and others in close future, or haematologic malignancies.
NON_2019_0011_GR